The breast cancer working group presentation was divided into three sections: The epidemiology, pathology and treatment of breast cancer

Japanese Journal of Clinical Oncology

Volumn 40, Issue SUPPL. 1, 2010, Pages

  Toi, Masakazu ^a   Ohashi, Yasuo ^b   Seow, Adeline ^c   Moriya, Takuya ^d   Tse, Gary ^e   Sasano, Hironobu ^f   Park, Byeong Woo ^g   Chow, Louis W C ^h   Laudico, Adriano V ⁱ   Yip, Cheng Har ^j   Ueno, Ei ^k   Ishiguro, Hiroshi ^l   Bando, Hiroko ^m  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Yonsei University College of Medicine   (South Korea)

^h UNIVERSITY OF HONG KONG   (Hong Kong)

ⁱ UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^j UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^k TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

^l KYOTO UNIVERSITY HOSPITAL   (Japan)

^m UNIVERSITY OF TSUKUBA   (Japan)

more..

Author keywords

Aromatase; Breast cancer; Epidemiology; HER2; Hormone receptor

Indexed keywords

ANASTROZOLE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LETROZOLE; PIPENDOXIFENE; TAMOXIFEN;

ARTICLE; BREAST CANCER; HUMAN; INCIDENCE; INTRADUCTAL CARCINOMA; MORTALITY; PROTEIN EXPRESSION; ASIA; BREAST NEOPLASMS; COMPARATIVE STUDY; FEMALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ASIA; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 77957273004     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq122     Document Type: Article

References (11)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Chia KS, Reilly M, Tan CS, Adami HO, Hall P, Mow B, et al. Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 2005;113:302-6.
3. Seow A, Duffy SW, McGee MA, Lee J, Lee HP. Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol 1996;25:40-5.
4. Pirie K, Beral V, Peto R, Roddam A, Reeves G, Green J, Million Women Study Collaborators. Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol 2008;37:1069-79.
5. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
6. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.
7. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer 2009;16:1103-23 (20 July, Epub).
8. Jiralerspong S, Palla SL, Giordano SH, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM, et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 2009;27:3297-302 (1 June, Epub).
9. Jin Y, Desta Z, Stearns V, Rae JM, Hayes DF, Flockhart DA, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005;97:30-9.
10. Fujita K. Cytochrome P450 and anticancer drugs. Curr Drug Metab 2006;7:23-37.
11. Dixon JM, Renshaw L, Young O, Cameron DA, A'Hern RP, Dowsett M, et al. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in post-menopausal women with breast cancer. J Clin Oncol 2008;26:1671-6.